Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats
about
Improved efficacy and reduced toxicity of doxorubicin encapsulated in sulfatide-containing nanoliposome in a glioma modelEvaluation of the use of therapeutic peptides for cancer treatmentA novel small peptide as an epidermal growth factor receptor targeting ligand for nanodelivery in vitroTunable ultrasmall visible-to-extended near-infrared emitting silver sulfide quantum dots for integrin-targeted cancer imagingRGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancerA new target ligand Ser-Glu for PEPT1-overexpressing cancer imagingDetection and imaging of aggressive cancer cells using an epidermal growth factor receptor (EGFR)-targeted filamentous plant virus-based nanoparticle.The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluationCyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.Current trends in the use of liposomes for tumor targetingThe interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior.Review peptide-targeted liposomes for selective drug delivery: Advantages and problematic issues.Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature.Novel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery.Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinoma.[Pyr1]-Apelin-13 delivery via nano-liposomal encapsulation attenuates pressure overload-induced cardiac dysfunction.Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review.Pyrrolysine-inspired protein cyclization.Uptake and Intracellular Fate of Peptide Surface-Functionalized Silica Hybrid Magnetic Nanoparticles In Vitro
P2860
Q28541327-5DEF2640-7876-46FA-AACE-1C30CA3D57E4Q29048586-66EC792E-6DC1-4AB4-BF20-872CE82A5DC4Q34692050-D85DA5F0-EB30-4EC9-ACEA-441E22B9DAD3Q35027207-6D6B4344-8058-4E2E-AD09-3D9E79CB1D42Q35970627-B88DF97E-2E33-4EF5-A89D-99A49F003A61Q36467648-1D528519-AFFA-4C56-BC40-9ECD563651BCQ36879532-A3C9261E-0CE0-4FEE-A96F-A91E29AC527FQ37027655-874887DC-4D56-4C1A-9117-2CC955D2A53EQ37705643-6288DC4C-82FB-4E07-9F93-3B2B3D9A1E53Q38126543-9D62213A-EF67-4F53-BB7A-3967D46F9898Q38176391-0893A46D-D188-4704-ADBF-82833F1A737FQ38502588-9E84F603-FA19-4DB4-8A07-262CB292E15CQ38564219-C7D3C92E-2A24-45E7-9D76-D663BDB4B355Q39036547-42EA89A9-C9A2-4E7F-87A7-6F02943A22DDQ39086982-1DA4A1A7-D93C-44D6-B12F-41ABC43497DCQ41383344-1D1E2E55-1350-43B4-85B2-CB21262D3417Q47190264-AD87EED1-1673-4110-A227-09EC0E214B60Q53496588-4FDED3D0-A241-484B-9394-D000B29D671FQ58493109-689416FC-80D2-4FD9-ACBA-75260F166AD5
P2860
Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cyclic RGD peptide-modified li ...... roved pharmacokinetics in rats
@ast
Cyclic RGD peptide-modified li ...... roved pharmacokinetics in rats
@en
type
label
Cyclic RGD peptide-modified li ...... roved pharmacokinetics in rats
@ast
Cyclic RGD peptide-modified li ...... roved pharmacokinetics in rats
@en
prefLabel
Cyclic RGD peptide-modified li ...... roved pharmacokinetics in rats
@ast
Cyclic RGD peptide-modified li ...... roved pharmacokinetics in rats
@en
P2093
P2860
P356
P1476
Cyclic RGD peptide-modified li ...... roved pharmacokinetics in rats
@en
P2093
P2860
P304
P356
10.2147/IJN.S33541
P407
P577
2012-07-18T00:00:00Z